About Satellite Bio
Satellite Bio is a company based in Cambridge (United States) founded in 2019 by Arnav Chhabra and Christopher Chen.. Satellite Bio has raised $110 million across 2 funding rounds from investors including Lightspeed Venture Partners, aMoon and Polaris Partners. The company has 21 employees as of December 31, 2021. Satellite Bio offers products and services including SAT Platform and Tissue Therapeutics. Satellite Bio operates in a competitive market with competitors including KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others.
- Headquarter Cambridge, United States
- Employees 21 as on 31 Dec, 2021
- Founders Arnav Chhabra, Christopher Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Satellite Biosciences Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$110 M (USD)
in 2 rounds
-
Latest Funding Round
$91 M (USD), Series A
Feb 25, 2022
-
Investors
Lightspeed Venture Partners
& 5 more
-
Employee Count
21
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Satellite Bio
Satellite Bio offers a comprehensive portfolio of products and services, including SAT Platform and Tissue Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables expansion and delivery of solid organ cells for regenerative therapies.
Delivers living cells to repair or replace organ functions like the liver.
Unlock access to complete
Unlock access to complete
Funding Insights of Satellite Bio
Satellite Bio has successfully raised a total of $110M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $91 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $91.0M
-
First Round
First Round
(02 Nov 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Series A - Satellite Bio | Valuation | aMoon | |
| Nov, 2020 | Amount | Seed - Satellite Bio | Valuation | Lightspeed Venture Partners , aMoon |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Satellite Bio
Satellite Bio has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Lightspeed Venture Partners, aMoon and Polaris Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Founded Year | Domain | Location | |
|
Venture capital investments in healthcare are focused on by aMoon.
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Satellite Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Satellite Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Satellite Bio Comparisons
Competitors of Satellite Bio
Satellite Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanotechnology-based red blood cell substitutes are developed.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| domain | founded_year | HQ Location |
Cell-based skin substitutes are developed for therapeutic and research uses.
|
|
| domain | founded_year | HQ Location |
Engineered liver tissues are developed for liver disease treatments.
|
|
| domain | founded_year | HQ Location |
Tissue engineering technologies for cardiovascular regenerative surgeries are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Satellite Bio
When was Satellite Bio founded?
Satellite Bio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Satellite Bio located?
Satellite Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Satellite Bio a funded company?
Satellite Bio is a funded company, having raised a total of $110M across 2 funding rounds to date. The company's 1st funding round was a Seed of $19M, raised on Nov 02, 2020.
How many employees does Satellite Bio have?
As of Dec 31, 2021, the latest employee count at Satellite Bio is 21.
What does Satellite Bio do?
Satellite Bio was founded in 2019 in Cambridge, United States, and operates in the regenerative medicine sector. Proprietary implantable satellite organs are developed through synthetic biology and tissue engineering to support living therapeutic solutions. Hydrogel grafts are created, and in vitro assays are conducted as part of cell therapy efforts. Focus is placed on advancing treatments in this field.
Who are the top competitors of Satellite Bio?
Satellite Bio's top competitors include KaloCyte, Stratatech Corp and Morphocell Technologies.
What products or services does Satellite Bio offer?
Satellite Bio offers SAT Platform and Tissue Therapeutics.
Who are Satellite Bio's investors?
Satellite Bio has 6 investors. Key investors include Lightspeed Venture Partners, aMoon, Polaris Partners, Catalio Capital Management, and Waterman Ventures.